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Abstract
Background: Cyclic AMP-dependent protein kinase (PKA) plays a central role in regulation of
energy metabolism. Upon stimulation of testicular Sertoli cells by follicle stimulating hormone
(FSH), glycolysis is activated to increase the production of nutrients for the germ cells, and a new
regulatory subunit of cAMP-dependent protein kinase, RIIβ , is induced. We have previously shown
that production of the transcription factor C/EBPβ  is rapidly increased by FSH and cAMP in primary
Sertoli cell cultures, and that C/EBPβ  induces the RIIβ  promoter.
Results: In this work we show that USF1, USF2 and truncated USF isoforms bind to a conserved
E-box in the RIIβ  gene. Interestingly, overexpression of USF2, but not USF1, led to inhibition of
both cAMP- and C/EBPβ -mediated induction of RIIβ . Furthermore, Western blots show that a
novel USF1 isoform is induced by cAMP in Sertoli cells.
Conclusions: These results indicate that the expression of various USF isoforms may be regulated
by cAMP, and that the interplay between USF and C/EBPβ  is important for cAMP-mediated
regulation of RIIβ  expression. The counteracting effects of USF2 and C/EBPβ  observed on the RIIβ
promoter is in accordance with the hypothesis that C/EBP and USF play opposite roles in regulation
of glucose metabolism.
Background
Follicle stimulating hormone (FSH) regulates sperma-
togenesis through the somatic Sertoli cells of the testis [1].
Sertoli cells act as "nursing" cells and supplies germ cells
with energy and controls the biochemical environment in
which they develop [2]. Among the FSH-regulated func-
tions are increased glucose uptake and oxidation. In re-
sponse to glucose, transcription of several glycolytic and
lipogenic genes are activated through the glucose/carbo-
hydrate/insulin response element (GIRE, ChoRE or IRE)
[3,4]. Upstream stimulatory factors (USF) 1 and 2 are
characterized by a basic/helix loop helix/leucine zipper
domain responsible for dimerization and DNA binding,
and are major components of the GIRE complex [5–8].
The main USF isoforms USF1 (43 kDa) and USF2 (44
kDa) are ubiquitously expressed and encoded by separate
genes [9–11]. In addition, more isoforms of USF2 are pro-
duced due to alternative splicing and utilization of differ-
ent translation start sites [12,13]. USF factors exist as
homo and heterodimers, and the heterodimer of USF1/
USF2a seems to dominate, although there are cell-type
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specific variations [12]. USF1 and USF2 show different
transactivating potential, and USF2 appears to be the
functional transactivator of the GIRE complex, although
both USF1 and USF2 are important for sustained dietary-
induced expression of the fatty acid synthase gene in liver
[14].
USF isoforms are important for expression of several
genes involved in Sertoli cell growth and differentiation.
Among genes that are stimulated by FSH/cAMP during the
period of maturation of Sertoli cells (15 to 20 days of age
in rats), are several subunits of cAMP-dependent protein
kinase (PKA), the serine/threonine kinase mainly respon-
sible for the downstream effects of FSH [15]. Expression of
the RIIβ  regulatory subunit of cAMP-dependent protein
kinase is highly induced (50-fold) at the mRNA level in
primary cultures of rat Sertoli cells as a late response to
cAMP peaking at 12 hours [16]. We have demonstrated
that expression of CAAT/Enhancer binding protein β  (C/
EBPβ ) is induced by cAMP with rapid kinetics in Sertoli
cells, and that C/EBPβ  is responsible for induction of late
response genes like the RIIβ -gene [17]. The RIIβ  promoter
contains a conserved E-box/HLH element in the basal
promoter localized at -280 to -275 relative to the func-
tional ATG [18]. This element is shown to be important
for cAMP-responsiveness in granulosa cells, and it has
been shown to bind both USF and Myc in CHO and NB2a
cells [18,19]. In this work, we show that USF isoforms
may regulate cAMP responsiveness of the RIIβ  promoter
by modulating the effect of C/EBP, and that the formation
of USF isoforms may be regulated by cAMP in Sertoli cells.
Results
USF complexes are formed on the RIIβ  promoter
A specific complex that formed a Dnase I footprint (-306
to -265) in the cAMP-responsive region of the RIIβ  pro-
moter in granulosa cells [18], covers a consensus E-box
(CACGTG) known to bind helix-loop-helix (bHLH) tran-
scription factors. Electrophoretic mobility shift assay (EM-
SA) with extracts from Sertoli cells demonstrated specific
binding to the conserved element using the footprinted
region as probe [20]. When incubated with proteins from
Sertoli cell nuclear extracts at least five complexes were
formed (Fig. 1, complex I to V). We found that USF2 anti-
body shifted complex I and III (Fig. 1 lanes 3 and 4),
whereas complex II and IV were completely shifted with
USF1 antibody, suggesting that the USF complexes con-
tained homodimers. Complex V was not shifted by anti-
bodies directed against N-terminal parts of USF1 or USF2,
but with antibodies directed against the C-terminal DNA-
binding region of USF2 (Fig. 1 lane 3). Thus, this complex
contained truncated USF2. A small shift in mobility of this
complex was observed in extracts prepared from Sertoli
cells treated with 8-CPT-cAMP for 6 h (data not shown).
Experiments using various protease inhibitors indicated
that the changes in complex mobility were due to inhibi-
tory effects of PKA on the protease calpain. The truncated
USF complexes forming complexes III to IV were abol-
ished in the presence of calpain inhibitor I (ALLN) (un-
published results).
A 31-kDa USF1 isoform is induced by cAMP
In order to study the existence of different variants of USF
expressed under stimulated and basal conditions, we per-
formed immunoblotting experiments with antibodies
against C-terminal regions of USF1 and USF2. For USF1,
we observed that a new immunoreactive protein of about
31 kDa was formed only in nuclear extracts from cAMP-
stimulated Sertoli cells (Fig. 2A). This isoform was not sol-
uble, but associated with a 1% Triton extractable fraction
(not shown). In contrast, we found no significant changes
in USF2 protein levels or mobility following stimulation
by cAMP (Fig. 2B). Other truncated USF1 or USF2 isofor-
ms could not be detected in this assay, which may indicate
that the levels of isoforms forming complex V (Fig. 1) are
very low relative to the full-length protein. We were not
able to relate the appearance of the novel 31 kDa USF1
isoform to changes in USF complex formation in EMSA.
Figure 1
USF isoforms bind to the RIIβ  E-box. A [32P]-labelled
oligonucleotide from the RIIβ  promoter region (-305 to -
268) was incubated with Sertoli cell nuclear extracts and sub-
jected to EMSA. Supershift experiments were performed
with 2 µl of antiserum against USF1 N-terminal region (lane
2), USF2a C-terminal sequences (lane 3), or USF2 N-terminal
sequences (lane 4).
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Formation of the truncated USF1 isoform in cAMP-treated
cells was not affected by addition of calpain inhibitor (un-
published results).
USF2 inhibits cAMP-mediated induction of the RIIβ  pro-
moter
We investigated the function of USF isoforms in regula-
tion of the RIIβ  promoter, using a CAT reporter containing
the basal RIIβ  promoter including the consensus E-box
(Fig. 3A) and expression vectors for USF1, USF2a and
USF2b isoforms. We found that none of the USF isoforms
affected basal transcription from the RIIβ  promoter (not
shown) whereas both splice variants of USF2 (a and b) re-
duced cAMP-stimulated levels of reporter expression to
25%. USF1, however, had no inhibitory effect on the
cAMP-mediated induction of RIIβ . Fig. 3B shows a dose-
dependent reduction of cAMP responsiveness with in-
creasing amounts of USF2a expression vector with a 50%
reduction in reporter activity at 75 ng of USF2a vector and
a 75% inhibition at 750 ng of USF2a vector.
USF2 inhibits C/EBP-mediated induction of the RIIβ  pro-
moter
We have previously reported that some of the late induc-
tion of RIIβ  by cAMP depends on the rapid cAMP-mediat-
ed increase in C/EBPβ  expression [17]. To test the effect of
different USF isoforms on C/EBPβ -mediated induction of
the RIIβ  promoter, we transfected combinations of the
transcription factors (Fig. 4). As previously reported, the
full-length LAP-form of C/EBPβ  induced the RIIβ  promot-
er 5–6-fold, whereas the C/EBPβ  LIP-form lacking the
transactivating region had no effect. Co-transfecting USF1
had no significant effect on C/EBPβ -mediated induction,
but USF2a (1:1, USF2a:C/EBPβ  expression vectors) re-
duced induction by 60%, indicating that USF2a may in-
terrupt the ability of C/EBPβ  to transactivate the RIIβ
promoter.
Discussion
The promoters of several genes induced by FSH in Sertoli
cells and granulosa cells, including c-Fos, transferrin, fol-
licle stimulating hormone receptor, SF-1 genes and the
RIIβ  gene, contain functional E-box elements [21–24]. We
found that several USF complexes containing full-length
USF1 and USF2 as well as truncated versions, are formed
at the consensus E-box/HLH-binding element in the RIIβ
promoter in Sertoli cell nuclear extracts.
USF1 and USF2 display identical dimerization and DNA
binding domains, but the transactivating regions differ
[25]. USF1 and USF2 obviously serve different, yet over-
lapping functions, and regulating the relative USF1/USF2
levels may be decisive for the pattern of USF-mediated
gene expression, which has been shown in studies of USF
knockout mice. The USF2 -/- mouse has obvious growth
defects and reduced fertility [25], whereas the USF1-defi-
cient mice are viable and fertile with minor behavioural
disturbances. A severe delay in glucose-mediated regula-
tion of the GIRE-containing fatty acid synthase (FAS) gene
is found in both USF-deficient mice, although insulin re-
sponse was unaltered, indicating that the USF1/USF2 het-
erodimer is implicated in FAS expression [14].
We have previously shown that C/EBPβ  functions as a sec-
ondary effector of cAMP signaling on slow response genes
in Sertoli cells, including RIIβ  [17]. Both C/EBP and the
RIIβ  E-box is shown be involved in cAMP responsiveness
of the RIIβ  gene [17,18].
Our present results indicate that USF2 disturbs this C/
EBPβ -mediated transactivation of RIIβ . No consensus C/
EBPβ  binding site is found in the promoter construct re-
sponsive to cAMP and C/EBPβ , but a possibility exists that
C/EBPβ  attach to the RIIβ  promoter through protein/pro-
tein interactions with USF1 or other members of the tran-
scriptional unit formed at the E-box. C/EBP is previously
reported to be an important accessory factor for transacti-
vation by several other transcription factors [26]. C/EBPβ
was shown to transactivate the α 1-acid glycoprotein gene
promoter even when mutated in the DNA-binding do-
main, and this activation appeared to depend on protein-
Figure 2
A novel USF1 isoform is induced by cAMP. Immunob-
lotting was performed with antibodies specific for the C-ter-
m i n a l  r e g i o n s  o f  U S F 1  ( P a n e l  A )  o r  U S F 2  ( P a n e l  B )  o n
stimulated (+, 100 µM 8-CPT-cAMP, 28 h) or unstimulated (-
) nuclear extracts. 20 µg of nuclear exracts was loaded in
each lane, and equal loading was determined by coomassie
staining.
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protein interaction with glucocorticoid receptor through
the leucine zipper region [27]. Recently, a conserved do-
main in C/EBPα  and C/EBPβ  was shown to mediate cAMP
responsiveness, strengthening the fact that C/EBP may be
characterized as a cAMP-responsive nuclear regulator
[28,29]. On the COX-2 promoter in granulosa cells,
cAMP-mediated regulation was shown to be mediated pri-
marily by an E-box that bind USF1 and USF2 isoforms in
a manner resembling the RIIβ  E-box in Sertoli cells [30].
Transactivation of the COX-2 gene in skin carcinoma cells
is highly dependent on this E-box together with a C/EBP
binding site that bind C/EBPβ  and C/EBPδ  [31]. These
data strengthens a model of formation of a cAMP-respon-
sive unit (CRU) containing USF and C/EBP. We propose a
model of interaction between USF and C/EBPβ  by which
USF2 inhibits the cAMP responsiveness of C/EBPβ , either
through interacting with the domain mediating the cAMP
responsiveness or by competing with USF1.
The cAMP-regulated formation of a 31-kDa USF1 isoform
may also play a role in formation of the RIIβ  CRU. This
truncated USF1 isoform may result from proteolytic cleav-
age or may be a novel splice variant. In granulosa cells, it
has previously been shown that the level of N-terminally
truncated USF2 is regulated by cAMP. Binding of truncat-
ed USF2 to a HLH element in the prostaglandin G/H syn-
thase 2 (PGHS-2) promoter was abolished in extracts
from cells stimulated by human chorionic gonadotrophin
(hCG) which signals through cAMP [32].
Other reports have suggested a role for USF in inhibition
of transcriptional activation mediated by other transcrip-
tion factors. An inhibitory effect of USF on Myc-mediated
cellular proliferation has been demonstrated in HeLa cells
[33], and a non-canonical HLH element inhibits expres-
sion of the fibroblast growth factor binding protein (FGF-
BP) in several carcinoma cells [34]. Furthermore, USF2 in-
hibits binding of hypoxia-inducible factor-1 (HIF-1) to
the plasminogen activator inhibitor -1 (PAI-1) gene in
hepatocytes in order to disturb transcriptional activation
[35]. Our results add C/EBPβ -mediated activation of RIIβ
to the mechanisms inhibited by USF. An opposite role of
USF and C/EBP could also be explained by the counteract-
ing effects these transcription factors have on glucose me-
tabolism. Whereas USF induces expression of enzymes
involved in glycolysis, C/EBPβ  regulates gluconeogenesis
mainly by activating phosphoenolpyruvate carboxykinase
(PEPCK) [36,37].
It has recently been reported that USF is implicated in
transcriptional activation of the 1a promoter of the RIα
gene in skeletal muscle cells [38]. Regulating the relative
levels of RIα  versus RIIβ  is physiologically important eg.
in lipid metabolism [39,40], and a possible function of
USF in tuning RIα /RIIβ  ratio by activating RIα  transcrip-
tion and inhibiting RIIβ  transcription is an interesting tar-
get of further investigation.
Figure 3
USF 2A inhibits cAMP-mediated induction of RIIβ . A
reporter construct containing the region (-395 to -123) from
the RIIβ  promoter was transfected into Sertoli cell primary
cultures together with expression vectors for USF1, USF2a
and USF2b isoforms or the corresponding empty expression
vector. Empty expression vector was added to ensure a total
of 2 µg of DNA transfected in each well. The cells were stim-
ulated for 28 h with 100 µM of 8-CPT-cAMP (black and grey
bars) or left untreated (open bars). Reporter activity is
shown relative to the cAMP-stimulated level that is set to
100 (black bar). Data are normalized for expression of luci-
ferase from the internal control plasmid. Panel A: Reporter
expression levels in unstimulated (open bar) and stimulated
cells in the absence (black bar) or presence of expression
vectors for USF1 (1), USF2a (2a) or USF2b (2b)(grey bars).
Panel B: Reporter levels in the absence (black bar) or pres-
ence of different concentrations of USF2a expression vector
(0 to 750 ng, grey bars). Three separate transfections were
performed in triplicate.
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Conclusions
1. USF1 and USF2, as well as truncated USF isoforms,
bind to a consensus E-box in the RIIβ  promoter in Sertoli
cells.
2. Cyclic AMP induces expression of a novel 31-kDa USF1
isoform.
3. Overexpression of USF2, but not USF1, inhibits cAMP-
mediated and C/EBPβ -mediated induction of the RIIβ
promoter.
Materials and methods
Antibodies
USF antibodies specific for USF1 amino acids 83 to 157
(USF1N), USF2a amino acids 1 to 49 (USF2N) and
USF2a/b amino acids 298 to 346 (USF2C) [12].
Preparation and stimulation of cell cultures
Primary cultures of rat Sertoli cells were made from testes
of 19 days old Sprague-Dawley rats (B&K Universal AS,
Nittedal, Norway) according to the method of Dorrington
et al. with some modifications [41]. Culturing and trans-
fections were performed as described elsewhere [42]. Two
days after transfections, the medium was changed, and in-
cubation was continued in the presence or absence of 100
µM 8-(4-chlorophenyl)thio-cAMP (8-CPT-cAMP) (Sigma,
St Louis, MO).
Preparation of nuclear extracts
Nuclear extract from Sertoli cells (12 ×  106) were prepared
by solubilization of nuclei in 0.4 M NaCl as described pre-
viously [17].
DNA-Protein complex analysis
Electrophoretic mobility shift assays (EMSAs) were per-
formed using a double stranded [32P]-end-labeled oligo-
nucleotide covering the consensus E-box/HLH element
(underlined) and flanking sequences from the RIIβ  pro-
moter (-305, 5'-GATCGCCGGGTTGCCATGGTTT CCG-
GGGAT CACGTGGGCGCGCGG-3', -268). For each
reaction, 5 ×  103 cpm of labeled probe was incubated with
5 µg of crude nuclear proteins from Sertoli cells and 1.0 µg
of poly dI:dC in a buffer containing 5 mM Hepes pH 7.9,
26 % glycerol, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM
PMSF, 150 mM KCl and 5 mM MgCl at room temperature
for 15 min. Supershift experiments were performed by in-
cubation of nuclear extract/DNA with 2 µl USF antibodies
for 30 min at 4°C. Samples were run in 6 % non-denatur-
ing polyacrylamide gels at 120–150 V in Tris-glycine buff-
er (50 mM Tris pH 8.5, 380 mM glycine, 2 mM EDTA) for
3 to 5 h at 4°C. Subsequently, gels were dried and subject-
ed to autoradiography.
Immunoblotting
20 µg of nuclear extract from Sertoli cell were loaded in
10% SDS PAGE gels and immunoblotting was performed
as previously described [42]. Equal loading was deter-
mined by coomassie staining.
Plasmids
A reporter construct containing the basal promoter of the
rat RIIβ  5'-flanking region (-394 to -123) upstream of a
CAT-reporter gene (pCATbasic; Promega, Madison, WI)
was used for assaying RIIβ  promoter activity [18]. Expres-
sion vectors for USF1, USF2a and USF2b inserted 3' of the
CMV promoter in pCR™3 (Invitrogen, Groningen, The
Netherlands) were used to overexpress USF isoforms [12].
C/EBPβ  LAP (full-length) and LIP (DNA-binding do-
main) expression vectors created in pCMV™3 (Stratagene,
La Jolla, CA) were appreciated gifts from Dr. Shizua Akira
(Hyogo College of Medicine, Hyogo, Japan). The luci-
ferase expression vector pGL3 Control (0.25 µg) (Prome-
ga, Madison, WI) was used as an internal marker for
transfection efficiency.
Transfections, Luciferase- and CAT-assays
After 2 days of culture in serum free medium, lipo-
fectamine-mediated transfections of primary cultures of
rat Sertoli cells were performed (2 µg DNA per well in 6-
Figure 4
USF2 inhibits induction of the RIIβ  promoter by C/
EBP. The RIIβ  promoter construct (-395 to -123) in the
CAT reporter vector was co-transfected with 500 ng of
expression vectors for USF1 (1), USF2a (2A) or C/EBPβ  Lap
(horisontally striped bars) or Lip (hached bars) isoforms or
combinations of these factors. Empty expression vector was
added to ensure a total of 2 µg of DNA transfected in each
well. Data represent reporter activities (CAT/Luc) relative to
transfection with the RIIβ  promoter construct under unstim-
ulated conditions, and were normalized for expression of
luciferase from a cotransfected control vector
(pGL3Control). Three separate transfections were per-
formed in triplicate.
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well plates) and assayed as described by Grønning et al
[17].
List of abbreviations
C; catalytic subunit, cAMP; cyclic adenosine monophos-
phate, CAT; chloramphenicol acetyl transferase, C/EBP;
CAAT/enhancer binding protein, ChoRE; carbohydrate re-
sponse element, CMV; cytalomega virus, 8-CPT-cAMP; 8-
(4-chlorophenyl)thio-cAMP, CREB; cAMP-response ele-
ment binding protein, EMSA; electrophoretic mobility
shift assay, FAS; fatty acid synthase, FSH; follicle stimulat-
ing hormone, GIRE; glucose/insulin response element,
hCG; human chorionic gonadotrophin, HLH; helix-loop-
helix, IRE; insulin response element, MHC; major histo-
compability complex, PGHS; prostaglandin G/H syn-
thase, PKA; cAMP-dependent protein kinase, R; regulatory
subunit, USF; upstream stimulating factor, WB; Western
blot.
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